Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Fusion Antibodies Plc"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2023 is -39.58% vs 14.29% in Mar 2022",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2023 is -116.67% vs 58.62% in Mar 2022",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'23",
        "Mar'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2.90",
          "val2": "4.80",
          "chgp": "-39.58%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-2.50",
          "val2": "-0.60",
          "chgp": "-316.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-2.60",
          "val2": "-1.20",
          "chgp": "-116.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-976.60%",
          "val2": "-277.60%",
          "chgp": "-69.90%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Annual Results Snapshot (Consolidated) - Mar'23

Mar'23

Mar'22

Change(%)

Net Sales

2.90

4.80

-39.58%

Operating Profit (PBDIT) excl Other Income

-2.50

-0.60

-316.67%

Interest

0.00

0.00

Exceptional Items

0.00

0.00

Consolidate Net Profit

-2.60

-1.20

-116.67%

Operating Profit Margin (Excl OI)

-976.60%

-277.60%

-69.90%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2023 is -39.58% vs 14.29% in Mar 2022

Consolidated Net Profit

YoY Growth in year ended Mar 2023 is -116.67% vs 58.62% in Mar 2022

All Annual Results